Christoph H Westphal's Net Worth
$481 Million
Who is Christoph H Westphal?
Christoph H Westphal has an estimated net worth of $481 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS INC, Sirtris Pharmaceuticals, Inc., Verastem, Inc., TScan Therapeutics, Inc., OvaScience, Inc., Flex Pharma, Inc., and MOMENTA PHARMACEUTICALS INC.
SEC CIK
Christoph H Westphal's CIK is 0001291961
Past Insider Trading and Trends
2013 was Christoph H Westphal's most active year for acquiring shares with 50 total transactions. Christoph H Westphal's most active month to acquire stocks was the month of May. 2008 was Christoph H Westphal's most active year for disposing of shares, totalling 115 transactions. Christoph H Westphal's most active month to dispose stocks was the month of December. 2015 saw Christoph H Westphal paying a total of $7,999,998.50 for 1,242,391 shares, this is the most they've acquired in one year. In 2018 Christoph H Westphal cashed out on 3,212,861 shares for a total of $2,941,052.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS INC (ALNY) Snapshot price: $168.785
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.51M |
—
|
—
| 2.51M |
Jun 3
| |||
Form 4
|
∞
| 312.5K |
$6.00 | $1,875,000.00 | 312.5K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sirtris Pharmaceuticals, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +32.33% | 181.8K |
$0.72 | $131,456.08 | 744.05K |
May 29
| |||
Form 4
| -1.20% | -6.81K |
$11.53 | -$78,498.71 | 562.26K |
Scheduled
|
Mar 5
| ||
Form 4
| -0.51% | -8.69K |
$11.63 | -$100,154.00 | 1.71M |
Scheduled
|
Mar 4
| ||
Form 4
| -3.38% | -20.19K |
$14.25 | -$287,732.40 | 577.76K |
Scheduled
|
Jan 8
| ||
Form 4
| -3.21% | -19.81K |
$13.47 | -$266,874.76 | 597.94K |
Scheduled
|
Jan 8
| ||
Form 4
| +0.61% | 2.83K |
—
|
—
| 467.76K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $14.01
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.40% | -2.65K |
$6.86 | -$18,165.28 | 665.22K |
Jun 30
| |||
Form 4
| -0.42% | -2.82K |
$10.49 | -$29,550.33 | 674.33K |
Mar 31
| |||
Form 4
|
∞
| 1.23M |
$6.50 | $7,999,998.50 | 1.23M |
Jan 28
| |||
Form 4
| +0.86% | 5.81K |
$9.19 | -$53,393.90 | 683.6K |
Jan 8
| |||
Form 4
| -0.41% | -2.77K |
$8.86 | -$24,542.20 | 677.79K |
Dec 31
| |||
Form 4
| +0.22% | 1.5K |
$8.50 | $12,750.00 | 687.02K |
Dec 19
| |||
Form 4
| -0.40% | -2.76K |
$8.60 | -$23,753.20 | 685.52K |
Sep 30
| |||
Form 4
| -0.79% | -5.53K |
$9.52 | -$52,645.60 | 694.73K |
Jun 30
| |||
Form 4
| +0.29% | 2K |
$7.56 | $15,120.00 | 700.26K |
May 14
| |||
Form 4
| -0.79% | -5.55K |
$10.36 | -$57,498.00 | 698.26K |
Mar 31
| |||
Form 4
| +1.95% | 13.43K |
$13.59 | -$168,407.28 | 703.81K |
Jan 7 - Jan 8
| |||
Form 4
| -0.93% | -6.49K |
$11.40 | -$74,008.80 | 690.38K |
Jan 2
| |||
Form 4
| +0.26% | 1.8K |
$9.78 | $17,598.00 | 696.87K |
Scheduled
|
Oct 31 - Nov 18
| ||
Form 4
| -0.87% | -6.09K |
$12.71 | -$77,454.74 | 695.07K |
Sep 30
| |||
Form 4
| -0.84% | -5.92K |
$13.88 | -$82,211.24 | 701.17K |
Jul 1
| |||
Form 4
| +0.26% | 1.8K |
$9.21 | $16,581.47 | 707.09K |
Scheduled
|
May 30 - Jun 7
| ||
Form 4
| +0.23% | 1.6K |
$9.51 | $15,221.43 | 705.29K |
Scheduled
|
May 13 - May 21
| ||
Form 4
| +0.23% | 1.6K |
$9.86 | $15,779.61 | 703.69K |
Scheduled
|
Apr 25 - May 3
| ||
Form 4
| +0.26% | 1.8K |
$9.27 | $16,692.13 | 702.09K |
Scheduled
|
Apr 9 - Apr 17
| ||
Form 4
| -0.71% | -5.04K |
$9.52 | -$47,463.27 | 700.29K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| +0.23% | 1.6K |
$9.19 | $14,699.00 | 705.33K |
Scheduled
|
Mar 13 - Mar 21
| ||
Form 4
| -4.98% | -36.86K |
$9.37 | -$345,415.68 | 703.73K |
Mar 12
| |||
Form 4
| +0.22% | 1.6K |
$9.72 | $15,548.41 | 740.6K |
Scheduled
|
Feb 25 - Mar 5
| ||
Form 4
| +3.74% | 26.63K |
$9.90 | $7,919.10 | 739K |
Scheduled
|
Dec 28 - Feb 6
| ||
Form 4
| +0.15% | 1.1K |
$10.00 | $10,995.02 | 712.37K |
Scheduled
|
Jan 18 - Jan 29
| ||
Form 4
| +0.25% | 1.8K |
$9.24 | $16,637.64 | 711.27K |
Scheduled
|
Dec 21 - Jan 2
| ||
Form 4
| +41.09% | 206.61K |
—
|
—
| 709.47K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
∞
| 2.87M |
$10.00 |
—
| 2.87M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.28M |
$15.00 |
—
| 1.28M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OvaScience, Inc. (TPST) Snapshot price: $4.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.69% | 100K |
$10.00 | $1,000,000.00 | 3.82M |
Mar 7
| |||
Form 4
|
∞
| 4.85K |
$10.53 | $51,070.50 | 4.85K |
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 3.3M |
—
|
—
| 3.3M |
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||